Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1997-9-18
pubmed:abstractText
All of the 88 episodes of beta-haemolytic streptococcal bacteremia (2.9% of all bacteremias) in adult patients during the years 1987-94 in a university hospital were reviewed. 38 bacteremias (43%) were caused by group A, 24 (27%) by group B, 3 (4%) by group C, and 23 (26%) by group G beta-haemolytic streptococcal. There was a statistically significant increase in group A and decrease in group C and G bacteremias (p < 0.02) compared to an earlier 8-year period in the same hospital, although the total number of streptococcal bacteremias remained the same. The most common T types of group A streptococcal strains were T11 (26%), T28 (14%), T6 and T1 (11% each), and T12 (8%). Cardiovascular disease, skin lesions, malignancy, and alcohol abuse were the most common underlying conditions. The most usual types of infection were skin (47%) and respiratory tract infections (23%). The overall mortality was 16%. It was highest in group A (24%) and lowest in group C (0%), 38% of patients with pneumonia died. All streptococcal strains were sensitive to penicillin, vancomycin, and cephalosporins. 11% of group A and 12% of all the strains had decreased sensitivity to erythromycin, 14 and 38% to tetracycline, and 0 and 2% to clindamycin, respectively.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0036-5548
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
233-8
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:9255881-Adolescent, pubmed-meshheading:9255881-Adult, pubmed-meshheading:9255881-Aged, pubmed-meshheading:9255881-Aged, 80 and over, pubmed-meshheading:9255881-Anti-Bacterial Agents, pubmed-meshheading:9255881-Bacteremia, pubmed-meshheading:9255881-Bacterial Typing Techniques, pubmed-meshheading:9255881-Cardiovascular Diseases, pubmed-meshheading:9255881-Clindamycin, pubmed-meshheading:9255881-Drug Resistance, Microbial, pubmed-meshheading:9255881-Erythromycin, pubmed-meshheading:9255881-Female, pubmed-meshheading:9255881-Finland, pubmed-meshheading:9255881-Humans, pubmed-meshheading:9255881-Male, pubmed-meshheading:9255881-Microbial Sensitivity Tests, pubmed-meshheading:9255881-Middle Aged, pubmed-meshheading:9255881-Neoplasms, pubmed-meshheading:9255881-Retrospective Studies, pubmed-meshheading:9255881-Skin Diseases, pubmed-meshheading:9255881-Streptococcal Infections, pubmed-meshheading:9255881-Streptococcus, pubmed-meshheading:9255881-Streptococcus agalactiae, pubmed-meshheading:9255881-Streptococcus pyogenes, pubmed-meshheading:9255881-Tetracycline
pubmed:year
1997
pubmed:articleTitle
A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period.
pubmed:affiliation
Department of Medicine, Helsinki University Central Hospital, Finland.
pubmed:publicationType
Journal Article